DTAB Agrees to Prohibit 16 FDCs Identified as Irrational Farhat Nasim15 May 2025 9:02 PM ISTDelhi: In a major move to strengthen drug safety and rational prescribing practices, the Drugs Technical Advisory Board (DTAB) has recommended a ban...
DCGI Told to Act Against Unapproved Antibiotic FDCs Farhat Nasim14 May 2025 7:48 PM ISTNew Delhi: The Drugs Technical Advisory Board (DTAB), India's apex drug advisory body, has taken a firm stance on curbing the irrational use of...
Ranitidine Under Scanner Again: DTAB, CDSCO Recommend New Safety Study, Tighter Monitoring Farhat Nasim6 May 2025 6:02 PM ISTNew Delhi: Amid continued global concerns over the presence of N-nitrosodimethylamine (NDMA) impurities in ranitidine, the Drugs Technical Advisory...
Substandard Drugs to Face Immediate License Suspension Under DTAB's New Recommendation Farhat Nasim5 May 2025 5:16 PM ISTNew Delhi: In a significant move to tighten quality control and safeguard public health, the Drugs Technical Advisory Board (DTAB) has recommended...
Batch of Tofajak Tablets earlier classified as NSQ now flagged as Spurious Dr. Divya Colin4 May 2025 6:00 PM ISTNew Delhi: Through a recent revised drug alert, the Central Drugs Standard Control Organization (CDSCO) has classified a batch of Tofacitinib Tablets...
Not a Nice Time For Nimesulide? DTAB, CDSCO Recommend Stringent Restrictions Farhat Nasim3 May 2025 7:31 PM ISTNew Delhi: Nimesulide, a widely used painkiller in India, is facing renewed regulatory scrutiny over its safety profile, with India's apex drug...
Batch of Telma AM earlier classified as NSQ now flagged as Spurious Farhat Nasim25 April 2025 8:30 PM ISTNew Delhi: Through a recent revised Drug Alert for January 2025, the Central Drugs Standard Control Organisation (CDSCO) has classified a batch of...
4 Diabetes Medication FDCs including Glimipride Metformin Strength banned by Health Ministry Farhat Nasim18 April 2025 6:13 PM ISTDelhi: The Central Drugs Standard Control Organization (CDSCO) has banned the manufacture, sale, and distribution of certain widely used strengths of...
Decades Old FDCs Under Review: DCGI Demands Proof of Efficacy Farhat Nasim28 Feb 2025 5:07 PM ISTCDSCO has given manufacturers a final 3-month deadline to submit required data or face regulatory action, including license cancellation.
Gastro-Resistant, Delayed-Release Drugs Now Under 'New Drug' Category Farhat Nasim27 Feb 2025 7:55 PM ISTNew Delhi: The Central Drugs Standard Control Organization (CDSCO) has directed all State and Union Territory (UT) Drugs Controllers to uniformly...
Glenmark, FDC Recall Hypertension, Glaucoma Drugs in US Farhat Nasim17 Feb 2025 8:17 PM ISTNew Delhi: Drug firms Glenmark Pharmaceuticals and FDC Ltd are recalling products in the US market due to manufacturing issues, according to the US...
Over 400 Drug Firms Face Action for Quality Violations: MoS Health Farhat Nasim6 Feb 2025 7:41 PM ISTNew Delhi: Over 400 enforcement actions, including show cause notices, production stoppages, and license cancellations, have been taken against drug...
